AMI SEMA

Price range: R490,00 through R790,00

Semaglutide 30mg in vial, pen or cartridge format. A single-compound listing, separate from our cagrilintide and semaglutide blend.

Out of stock

  • Pens and cartridges are made on order.
  • Peptides are received, stored and shipped cold.
Pay byDirect bank transfer

For laboratory research use only. This product is not a medicine and is not for human or veterinary use. It is not intended to diagnose, treat, cure or prevent any disease.

SKU: ARP-semaglutide Categories: ,

Semaglutide is listed here at 30mg, with a choice of vial, pen or cartridge. This page is for semaglutide alone. If you are looking for the two-compound blend, see Cagrilintide + Semaglutide instead.
The original discovery paper describes semaglutide as a GLP-1 analogue. That identifies its research background; it does not establish the composition, quality or clinical suitability of the item supplied by Aminos.
For a comparison of catalogue options, see Tirzepatide and Retatrutide. These are separate compounds, not alternative names for semaglutide.

Semaglutide is a lipid-modified GLP-1 receptor agonist. Its reference identity includes a non-standard amino acid and a side-chain modification, so an ordinary peptide sequence alone would describe the wrong molecule.

Identity and context

The discovery paper identifies two substitutions relative to human GLP-1, including Aib, and derivatization at lysine 26. The linker and fatty-acid group were part of the design used to change albumin binding and exposure. These features distinguish semaglutide from native GLP-1 and from other incretin analogues.

Reference classification

Modified peptide. The linked catalogue product is Semaglutide. This reference does not independently authenticate the material supplied.